240 related articles for article (PubMed ID: 24528044)
21. An Increased Chromosome 7 Copy Number in Endoscopic Bile Duct Biopsy Specimens Is Predictive of a Poor Prognosis in Cholangiocarcinoma.
Kato A; Naitoh I; Miyabe K; Hayashi K; Yoshida M; Hori Y; Natsume M; Jinno N; Asano G; Kato H; Kuno T; Takahashi S; Kataoka H
Dig Dis Sci; 2018 Dec; 63(12):3376-3381. PubMed ID: 30206756
[TBL] [Abstract][Full Text] [Related]
22. Aberrant methylation of HTATIP2 and UCHL1 as a predictive biomarker for cholangiocarcinoma.
Nanok C; Jearanaikoon P; Proungvitaya S; Limpaiboon T
Mol Med Rep; 2018 Mar; 17(3):4145-4153. PubMed ID: 29359783
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of p53 and Its Target Gene Expression as Potential Biomarkers of Cholangiocarcinoma in Thai Patients.
Puetkasichonpasutha J; Namwat N; Sa-Ngiamwibool P; Titapun A; Suthiphongchai T
Asian Pac J Cancer Prev; 2020 Mar; 21(3):791-798. PubMed ID: 32212809
[TBL] [Abstract][Full Text] [Related]
24. Gene-environment interaction involved in cholangiocarcinoma in the Thai population: polymorphisms of DNA repair genes, smoking and use of alcohol.
Songserm N; Promthet S; Pientong C; Ekalaksananan T; Chopjitt P; Wiangnon S
BMJ Open; 2014 Oct; 4(10):e005447. PubMed ID: 25335960
[TBL] [Abstract][Full Text] [Related]
25. Low expression of ARID1A correlates with poor prognosis in intrahepatic cholangiocarcinoma.
Yang SZ; Wang AQ; Du J; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
World J Gastroenterol; 2016 Jul; 22(25):5814-21. PubMed ID: 27433094
[TBL] [Abstract][Full Text] [Related]
26. LncRNA CCAT1 as the unfavorable prognostic biomarker for cholangiocarcinoma.
Jiang XM; Li ZL; Li JL; Zheng WY; Li XH; Cui YF; Sun DJ
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1242-1247. PubMed ID: 28387907
[TBL] [Abstract][Full Text] [Related]
27. Amplified in breast cancer 1 enhances human cholangiocarcinoma growth and chemoresistance by simultaneous activation of Akt and Nrf2 pathways.
Chen Q; Li W; Wan Y; Xia X; Wu Q; Chen Y; Lai Z; Yu C; Li W
Hepatology; 2012 Jun; 55(6):1820-9. PubMed ID: 22213475
[TBL] [Abstract][Full Text] [Related]
28. Circulating miR-106a is a Novel Prognostic and Lymph Node Metastasis Indicator for Cholangiocarcinoma.
Cheng Q; Feng F; Zhu L; Zheng Y; Luo X; Liu C; Yi B; Jiang X
Sci Rep; 2015 Nov; 5():16103. PubMed ID: 26534789
[TBL] [Abstract][Full Text] [Related]
29. A novel TFF2 splice variant (∆EX2TFF2) correlates with longer overall survival time in cholangiocarcinoma.
Kamlua S; Patrakitkomjorn S; Jearanaikoon P; Menheniott TR; Giraud AS; Limpaiboon T
Oncol Rep; 2012 Apr; 27(4):1207-12. PubMed ID: 22159958
[TBL] [Abstract][Full Text] [Related]
30. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of microRNA-203 in cholangiocarcinoma.
Li J; Gao B; Huang Z; Duan T; Li D; Zhang S; Zhao Y; Liu L; Wang Q; Chen Z; Cheng K
Int J Clin Exp Pathol; 2015; 8(8):9512-6. PubMed ID: 26464713
[TBL] [Abstract][Full Text] [Related]
32. MTHFR polymorphisms and Opisthorchis viverrini infection: a relationship with increased susceptibility to cholangiocarcinoma in Thailand.
Songserm N; Promthet S; Sithithaworn P; Pientong C; Ekalaksananan T; Chopjitt P; Parkin DM
Asian Pac J Cancer Prev; 2011; 12(5):1341-5. PubMed ID: 21875294
[TBL] [Abstract][Full Text] [Related]
33. Genomic and transcriptional alterations of cholangiocarcinoma.
Ito T; Sakurai-Yageta M; Goto A; Pairojkul C; Yongvanit P; Murakami Y
J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):380-7. PubMed ID: 24532422
[TBL] [Abstract][Full Text] [Related]
34. Genetic variants of nuclear factor erythroid-derived 2-like 2 associated with the complications in Han descents with type 2 diabetes mellitus of Northeast China.
Xu X; Sun J; Chang X; Wang J; Luo M; Wintergerst KA; Miao L; Cai L
J Cell Mol Med; 2016 Nov; 20(11):2078-2088. PubMed ID: 27374075
[TBL] [Abstract][Full Text] [Related]
35. An interleukin-6 receptor polymorphism is associated with opisthorchiasis-linked cholangiocarcinoma risk in Thailand.
Prayong P; Mairiang E; Pairojkul C; Chamgramol Y; Mairiang P; Bhudisawasdi V; Sripa B
Asian Pac J Cancer Prev; 2014; 15(13):5443-7. PubMed ID: 25041016
[TBL] [Abstract][Full Text] [Related]
36. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
[TBL] [Abstract][Full Text] [Related]
37. Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke
Surapaitoon A; Suttiprapa S; Mairiang E; Khuntikeo N; Pairojkul C; Bethony J; Brindley PJ; Sripa B
Korean J Parasitol; 2017 Jun; 55(3):295-304. PubMed ID: 28719954
[No Abstract] [Full Text] [Related]
38. Survival rate of extrahepatic cholangiocarcinoma patients after surgical treatment in Thailand.
Pattanathien P; Khuntikeo N; Promthet S; Kamsa-Ard S
Asian Pac J Cancer Prev; 2013; 14(1):321-4. PubMed ID: 23534746
[TBL] [Abstract][Full Text] [Related]
39. SOX4 is associated with poor prognosis in cholangiocarcinoma.
Wang W; Zhang J; Zhan X; Lin T; Yang M; Hu J; Han B; Hu S
Biochem Biophys Res Commun; 2014 Sep; 452(3):614-21. PubMed ID: 25181339
[TBL] [Abstract][Full Text] [Related]
40. Association of the c.3972C>T variant of the multidrug resistance-associated protein 2 Gene (MRP2/ABCC2) with susceptibility to bile duct cancer.
Hoblinger A; Grunhage F; Sauerbruch T; Lammert F
Digestion; 2009; 80(1):36-9. PubMed ID: 19451719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
